IMDZ - Immune Design Corp.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue7,19513,2609,5106,433
Cost of Revenue43,75445,61533,86123,384
Gross Profit-36,559-32,355-24,351-16,951
Operating Expenses
Research Development----
Selling General and Administrative16,25315,95915,13412,927
Non Recurring----
Others----
Total Operating Expenses60,00761,57448,99536,311
Operating Income or Loss-52,812-48,314-39,485-29,878
Income from Continuing Operations
Total Other Income/Expenses Net950-5,21640-4,273
Earnings Before Interest and Taxes-52,812-48,314-39,485-29,878
Interest Expense----
Income Before Tax-51,862-53,530-39,445-34,151
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-51,862-53,530-39,445-34,151
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-51,862-53,530-39,445-34,151
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-51,862-53,530-39,445-34,151